Background

There is an established link between depression and tobacco use among adults; however, to date, research has not explored the association of use of dual/poly tobacco products with symptoms and use of medication for depression.

Methods

Data were derived from a 2018 Texas population health assessment survey (n = 2034). Multivariable logistic and multinomial regressions were used to examine for associations between self-reported symptoms of depression and use of prescription medications for depression with use of dual/poly tobacco products.

Results

About 20% of adults used one tobacco product, while 9.7% used two or more products. Compared to those without depressive symptoms, those with depressive symptoms had greater odds of single (aOR: 1.66, 95% CI; 1.21 – 2.29) or dual/poly (aOR: 3.09, 95% CI; 1.92 – 4.96) tobacco product use relative to non-users; and relative to single product use, those with depressive symptoms had greater odds of dual/poly tobacco product use (aOR: 2.07; 95% CI, 1.30 – 3.32). Compared to those not using medication for depression, use of medication for depression was associated with a 1.80 (95% CI: 1.15 – 2.84) greater odds of dual/poly tobacco product use relative to non-users; and a 1.91 (95% CI: 1.14 – 3.19) greater odds of dual/poly product use relative to single product users.

Conclusions

Study findings call for primary care providers and psychiatrists to expand screening of individuals experiencing depressive symptoms and using medication for depression, to include assessment for dual/poly tobacco product use.

中文翻译：

---

双重和多重烟草使用与抑郁症状和抗抑郁药使用的关联

背景

在成年人中，抑郁症与烟草使用之间存在着既定的联系；然而，迄今为止，研究尚未探讨使用双重/多重烟草制品与症状和使用药物治疗抑郁症之间的关系。

方法

数据来自 2018 年德克萨斯州人口健康评估调查 (n = 2034)。多变量逻辑和多项回归用于检查自我报告的抑郁症状与使用抑郁症处方药与使用双重/多重烟草产品之间的关联。

结果

大约 20% 的成年人使用一种烟草产品，而 9.7% 的成年人使用两种或更多产品。与没有抑郁症状的人相比，有抑郁症状的人在单一（aOR：1.66, 95% CI; 1.21 – 2.29）或双重/多重（aOR: 3.09, 95% CI; 1.92 – 4.96）烟草制品使用方面的几率更高对非用户；相对于单一产品的使用，有抑郁症状的人使用双重/多重烟草产品的几率更大（aOR：2.07；95% CI，1.30 – 3.32）。与不使用药物治疗抑郁症的人相比，使用药物治疗抑郁症的人使用双重/多重烟草产品的几率比非使用者高 1.80 (95% CI: 1.15 – 2.84)；相对于单一产品用户，双重/多重产品使用的几率增加 1.91 (95% CI: 1.14 – 3.19)。

结论

研究结果呼吁初级保健提供者和精神科医生扩大对出现抑郁症状和使用抑郁症药物的个体的筛查，包括对双重/多重烟草产品使用的评估。